microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 327-333

  Mao, Yeqing ^a   Chen, Hong ^a   Lin, Yiwei ^a   Xu, Xin ^a   Hu, Zhenghui ^a   Zhu, Yi ^a   Wu, Jian ^a   Xu, Xianglai ^a   Zheng, Xiangyi ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Invasion; MicroRNA 330; Migration; Prostate cancer; Specificity protein 1

Indexed keywords

MICRORNA; MICRORNA 330; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; METASTASIS INHIBITION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR INVASION;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR;

EID: 84878182672     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2452     Document Type: Article

References (29)

1. Ambros V and Chen X: The regulation of genes and genomes by small RNAs. Development 134: 1635-1641, 2007. (Pubitemid 46796561)
2. Hutvágner G and Zamore PD: A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060, 2002.
3. Hwang HW and Mendell JT: microRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 96 (Suppl): R40-R44, 2007.
4. Ryan BM, Robles AI and Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402, 2010.
5. Kasinski AL and Slack FJ: Epigenetics and genetics. microRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864, 2011.
6. Weber MJ: New human and mouse microRNA genes found by homology search. FEBS J 272: 59-73, 2005.
7. Gaur A, Jewell DA, Liang Y, et al: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468, 2007. (Pubitemid 46548930)
8. Ruike Y, Ichimura A, Tsuchiya S, et al: Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J Hum Genet 53: 515-523, 2008.
9. Neville PJ, Conti DV, Krumroy LM, et al: Prostate cancer aggressiveness locus on chromosome segment 19q12-q13. 1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer 36: 332-339, 2003. (Pubitemid 36314516)
10. Slager SL, Schaid DJ, Cunningham JM, et al: Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet 72: 759-762, 2003. (Pubitemid 36255976)
11. Qu S, Yao Y, Shang C, et al: microRNA-330 is an oncogenic factor in glioblastoma cells by regulating SH3GL2 gene. PLoS One 7: e46010, 2012.
12. Lee KH, Chen YL, Yeh SD, et al: microRNA-330 acts as tumor-suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 28: 3360-3370, 2009.
13. Chintharlapalli S, Papineni S, Ramaiah SK and Safe S: Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 67: 2816-2823, 2007. (Pubitemid 46548971)
14. Sankpal UT, Goodison S, Abdelrahim M and Basha R: Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem 7: 518-525, 2011.
15. Pore N, Liu S, Shu HK, et al: Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 15: 4841-4853, 2004. (Pubitemid 39392201)
16. Baranwal S and Alahari SK: miRNA control of tumor cell invasion and metastasis. Int J Cancer 126: 1283-1290, 2010.
17. Iorio MV and Croce CM: microRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856, 2009.
18. Watahiki A, Wang Y, Morris J, et al: microRNAs associated with metastatic prostate cancer. PLoS One 6: e24950, 2011.
19. Chiefari E, Brunetti A, Arturi F, et al: Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2: 35, 2002.
20. Shi Q, Le X, Abbruzzese JL, et al: Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61: 4143-4154, 2001. (Pubitemid 32720983)
21. Yao JC, Wang L, Wei D, et al: Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10: 4109-4117, 2004. (Pubitemid 38812490)
22. Zannetti A, Del Vecchio S, Carriero MV, et al: Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 60: 1546-1551, 2000. (Pubitemid 30183423)
23. Chen JL, Attardi LD, Verrijzer CP, Yokomori K and Tjian R: Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79: 93-105, 1994. (Pubitemid 24309516)
24. Furukawa T and Tanese N: Assembly of partial TFIID complexes in mammalian cells reveals distinct activities associated with individual TATA box-binding protein-associated factors. J Biol Chem 275: 29847-29856, 2000. (Pubitemid 32043870)
25. Majello B, Napolitano G, De Luca P and Lania L: Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters. J Biol Chem 273: 16509-16516, 1998. (Pubitemid 28311435)
26. Sadovsky Y, Webb P, Lopez G, et al: Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol 15: 1554-1563, 1995.
27. Murthy S, Ryan AJ and Carter AB: SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain. Biochem J 445: 229-236, 2012.
28. Qin H, Sun Y and Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274: 29130-29137, 1999.
29. Wang CH, Chang HC and Hung WC: p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription. J Cell Physiol 208: 246-252, 2006. (Pubitemid 43849011)